GlassScriptPhysician profile
Bradley B Andrew
NPI 1801013230
$11,574.05
in general payments reported to CMS, 2019-2025
51 companies · $1,880 in 2025
The $1,880 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,502 · 2022: $2,778 · 2023: $2,138 · 2024: $2,277 · 2025: $1,880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,227 · Education: $66.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,226.76 |
| Education | $66.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,340.26 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $802.35 | 2021-2024 | |
| Biogen, INC. | $603.76 | 2021-2025 | Vumerity, Tysabri |
| Pfizer INC. | $570.10 | 2023-2025 | |
| Ucb, INC. | $534.39 | 2021-2025 | Briviact, Rystiggo, Nayzilam |
| Mdd US Operations, LLC | $485.93 | 2022-2025 | Gocovri, Apokyn |
| Neurocrine Biosciences, INC. | $471.74 | 2021-2025 | Ingrezza, Ongentys |
| Harmony Biosciences LLC | $419.63 | 2022-2025 | Wakix |
| Emd Serono, INC. | $394.47 | 2021-2025 | Mavenclad |
| Acadia Pharmaceuticals INC | $380.56 | 2021-2025 | Nuplazid |
| Amneal Pharmaceuticals LLC | $345.43 | 2021-2024 | Rytary |
| Sk Life Science, INC. | $345.38 | 2021-2025 | |
| Celgene Corporation | $325.36 | 2021-2024 | Zeposia |
| Janssen Pharmaceuticals, INC | $267.82 | 2021-2022 | |
| Lilly USA, LLC | $249.29 | 2021-2025 | Emgality, Reyvow, Kisunla |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Andrew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.